Pfizer says COVID-19 booster shot offers protection against Omicron

Pfizer Inc. said Wednesday that a third shot of its coronavirus vaccine could offer sufficient protection against the new Omicron variant, while the two-dose regimen may be less effective, citing the results of an initial laboratory study.The U.S. pharmaceutical giant and its German partner BioNTech SE also said they started developing an Omicron-specific COVID-19 vaccine in late November and believe they can deliver it in March next year if needed.According to preliminary laboratory studies, a booster shot of the current COVID-19 vaccine can increase by 25-fold the antibodies that would helREAD FULL ARTICLE